Migralgin (Paracetamol, Acetylsalicylic Acid, Caffeine)

Paracetamol reduces central prostaglandin synthesis, acetylsalicylic acid irreversibly blocks COX‑1 and COX‑2 enzymes decreasing peripheral prostaglandin production, and caffeine blocks adenosine receptors, providing mild stimulation and enhancing the analgesic effect of the other two agents, resulting in faster and stronger pain and fever relief.

The appropriate dose of Migralgin is determined by the prescribing healthcare professional based on the individual’s age, weight, medical condition and other medications. Patients should follow the dosage instructions on the product label or those provided by their prescriber.

Safety of Migralgin in pregnancy or while breastfeeding has not been fully established. Women who are pregnant, planning to become pregnant, or nursing should consult their healthcare provider before using this product to weigh potential benefits against possible risks.

To order Migralgin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and assistance with import documentation.

Compared with single‑ingredient products such as paracetamol alone, Migralgin adds acetylsalicylic acid for anti‑inflammatory effect and caffeine to boost analgesia, often providing faster and more complete relief for headache or migraine. However, the combination may carry higher risk of gastrointestinal irritation and bleeding than paracetamol alone.

Migralgin tablets should be stored at room temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keep the container tightly closed and out of reach of children.

Migralgin is taken orally with a glass of water. It can be taken with or without food, but if gastrointestinal upset occurs, it may be helpful to take the tablet with a small amount of food.

Serious risks include allergic reactions such as rash, angioedema or anaphylaxis, gastrointestinal bleeding or ulcer formation, and rare but severe liver injury. Patients should seek immediate medical attention if they experience signs of these conditions.

Migralgin should be avoided by individuals with a known allergy to aspirin, paracetamol or caffeine, those with active peptic ulcer disease, severe liver impairment, uncontrolled hypertension, or who are taking anticoagulants without medical supervision.